Skip to content
Clinical Trial Events
The Liver Meeting 2026

Talk Abstract Parallel track

Basic Mechanisms of MASH Progression

Sun, Nov 8, 2026 · 8:00–9:30 AM MST Convention Center: Bluebird Ballroom 1B, Colorado Convention Center

About this session

This session explores emerging mechanisms that govern the development and progression of metabolic dysfunction–associated steatotic liver disease and steatohepatitis. Presentations will examine how hepatocyte metabolic programs, macrophage efferocytosis, bile acid signaling, natural killer cell dysfunction, aging-related ferroptosis, and fibrosis-associated cellular states contribute to liver injury and fibrogenesis.

Speaker